Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
JRK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RNF220 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR4745 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MID1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
INPP4B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CPLX3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KCNN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HMGA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GPR65 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NCBP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PCBP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PDGFC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WDHD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SRSF10 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TFPI - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
H2AFY - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SRI - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CTGF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KIF18A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LRRFIP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on